Life Science REIT PLC Notice of Half Year Results (9844H)
02 August 2023 - 4:00PM
UK Regulatory
TIDMLABS
RNS Number : 9844H
Life Science REIT PLC
02 August 2023
2 August 2023
LEI: 213800RG7JNX7K8F7525
Life Science REIT plc
("Life Science REIT" or the "Company")
Notice of Half Year Results
Life Science REIT (LSE: LABS), the real estate investment trust
focused on UK life science properties, is pleased to announce that
it will report its interim results for the six months ended 30 June
2023 on Thursday 21 September 2023.
A presentation for analysts will be held at 9.30am on the
morning of the results announcement at the offices of Buchanan, 107
Cheapside, London EC2V 6DN. The presentation will be hosted by
Ironstone Asset Management, the Company's Investment Adviser.
Analysts who wish to attend the presentation, please RSVP to
lifesciencereit@buchanan.uk.com
Following the presentation, a recording will be made available
at the Company's website, https://lifesciencereit.co.uk
FOR FURTHER INFORMATION, PLEASE CONTACT:
Ironstone Asset Management - Investment Adviser +44 20 3011 2160
Simon Farnsworth
Joanna Waddingham, Head of Investor Relations
and Corporate Affairs
Joanna.Waddingham@ironstoneam.com
Link Company Matters Limited - Company Secretary
labs_cosec@linkgroup.co.uk
Panmure Gordon (UK) Limited - Joint Corporate
Broker +44 20 7886 2500
Alex Collins / Tom Scrivens
Jefferies International Limited - Joint Corporate
Broker +44 20 7029 8000
Tom Yeadon / Andrew Morris / Oliver Nott /
Harry Randall
G10 Capital Limited - AIFM +44 20 7397 5450
Maria Baldwin
Buchanan - Financial PR +44 20 7466 5000
Mark Court / Henry Wilson / Verity Parker
LifeSciencereit@buchanan.uk.com
Notes to editors
Life Science REIT is a specialist property business focused on
the UK's growing life science sector. The Company's portfolio of
assets is located across the "Golden Triangle" of research and
development hubs in Oxford, Cambridge and London's Knowledge
Quarter and its strategic vision is to become the property provider
of choice for life science companies in the UK.
Life Science REIT is addressing the acute demand-supply
imbalance for laboratory space in the "Golden Triangle", which is
characterised by low vacancy rates and prime rental increases. The
UK life science sector itself is benefiting from sustained growth
and demand for laboratory space.
The Company's diverse portfolio of assets ranges from a 20-acre
science park currently under development through to fully let
buildings, with an important part of the Company's strategy being
the conversion of existing properties to laboratory space.
The Company's investment policy is focused on capital growth
whilst also providing a growing level of income.
Life Science REIT trades on the Main Market of the London Stock
Exchange under the ticker LABS.
Further information is available at
https://lifesciencereit.co.uk. To sign up for email alerts, please
visit https://lifesciencereit.co.uk/investors/.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORFFFEITTILIIV
(END) Dow Jones Newswires
August 02, 2023 02:00 ET (06:00 GMT)
Life Science Reit (LSE:LABS)
Historical Stock Chart
From Apr 2024 to May 2024
Life Science Reit (LSE:LABS)
Historical Stock Chart
From May 2023 to May 2024
